| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8485500 | Vaccine | 2018 | 9 Pages |
Abstract
No immunologic interference was observed between RZV and PPSV23 when co-administered in adults â¥50â¯years. No safety concerns were raised.
Keywords
VZVPCV13VRRPPSV23MOPAZVLPIMDPHNpotential immune-mediated diseaseGMCIDPGMTTVCvaccine response rateCDCATPSafetyaccording-to-protocolInvasive pneumococcal diseaseEnzyme-linked immunosorbent assayELISAHerpes zosteryears of ageconfidence intervalMonthUnited States Centers for Disease Control and PreventionGeometric mean concentrationGeometric mean titerpostherpetic neuralgia23-Valent pneumococcal polysaccharide vaccine13-Valent pneumococcal conjugate vaccineVaricella-zoster virusImmune responseGlycoprotein E
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Céline Maréchal, Himal Lal, Airi Poder, Murdo Ferguson, Igwebuike Enweonye, Thomas C Heineman, Caroline Hervé, Paul Rheault, Jaak Talli, Dominique Wauters, Lidia Oostvogels,